Fresenius Medical Care (NYSE:FMS) Shares Gap Up – Should You Buy?

Fresenius Medical Care AG (NYSE:FMS)’s share price gapped up prior to trading on Friday . The stock had previously closed at $21.32, but opened at $21.93. Fresenius Medical Care shares last traded at $21.90, with a volume of 52,465 shares traded.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on FMS. Berenberg Bank assumed coverage on Fresenius Medical Care in a research report on Wednesday, November 6th. They set a “buy” rating and a $25.60 target price on the stock. Truist Financial upped their target price on Fresenius Medical Care from $22.00 to $23.00 and gave the company a “hold” rating in a research report on Monday, October 7th. Finally, StockNews.com assumed coverage on Fresenius Medical Care in a research note on Saturday, November 9th. They set a “strong-buy” rating on the stock. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $24.30.

Fresenius Medical Care Trading Up 4.0 %

The stock has a market capitalization of $13.02 billion, a PE ratio of 18.33, a P/E/G ratio of 0.97 and a beta of 0.91. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The company’s 50 day moving average price is $20.65 and its two-hundred day moving average price is $20.25.

Institutional Investors Weigh In On Fresenius Medical Care

A number of large investors have recently made changes to their positions in FMS. Allworth Financial LP raised its holdings in shares of Fresenius Medical Care by 53.1% during the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after acquiring an additional 581 shares during the period. Mercer Global Advisors Inc. ADV raised its position in Fresenius Medical Care by 4.5% in the second quarter. Mercer Global Advisors Inc. ADV now owns 14,581 shares of the company’s stock valued at $278,000 after purchasing an additional 624 shares during the period. Signaturefd LLC lifted its stake in shares of Fresenius Medical Care by 8.4% in the 2nd quarter. Signaturefd LLC now owns 8,713 shares of the company’s stock valued at $166,000 after purchasing an additional 672 shares during the last quarter. MML Investors Services LLC lifted its position in Fresenius Medical Care by 5.3% in the third quarter. MML Investors Services LLC now owns 15,019 shares of the company’s stock valued at $320,000 after buying an additional 753 shares during the last quarter. Finally, Ritholtz Wealth Management boosted its stake in Fresenius Medical Care by 2.5% during the second quarter. Ritholtz Wealth Management now owns 36,901 shares of the company’s stock worth $704,000 after buying an additional 895 shares during the period. 8.25% of the stock is currently owned by hedge funds and other institutional investors.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.